IP Library Granted Patent US 12,262,977
Granted Patent B2
US 12,262,977 · App. 17/989,225 · Granted Apr 1, 2025

Methods for tissue analysis, location determination and therapy thereof using optical radiation

Inventors: Joe Ting (Acton, MA); Tania To (Braintree, MA); Vincent Zuo (Boston, MA); James Wright (Roxbury, MA); Ben Apollonio (Lunenburg, MA); Charles Holland Dresser (Wayland, MA)
Assignee: Blossom Innovations
A61B5/0084A61B5/0031A61B5/4839A61B5/4887A61B5/6848A61B5/7405A61B5/742A61B10/0233A61B10/04A61B18/20A61B34/20A61M5/46A61B5/0538A61B5/4872A61B5/489A61B2018/00577A61B2034/2055
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,262,977
App. No.
17/989,225
Granted
Apr 1, 2025
Kind
B2
Abstract

A tissue detection and location identification apparatus can include, a first electrically conductive layer surrounding a lumen, an insulating layer surrounding the first electrically conductive layer, and a second electrically conductive layer circumferentially surrounding the insulating layer, where the insulating layer can electrically isolate the first electrically conductive layer from the second electrically conductive layer. A further insulating layer can surround the second electrically conductive layer. The first electrically conductive layer, the insulating layer, and the second electrically conductive layer can form a structure which has a first side and a second side disposed opposite to the first side with respect to the lumen, where the first side can be longer than the second side thereby forming a sharp pointed end via the first side at a distal-most portion. The exemplary configuration can be used for determination/detection of a tissue type, and/or determination of a location of insertion device/apparatus.

Claims (27)

1. A method of determining information associated with at least one target tissue of a patient using a needle comprising at least one lumen extending along a length thereof, a cladding layer applied to and circumferentially surrounding an exterior of the needle and an optically-transmissive coating applied to and circumferentially surrounding an exterior of the cladding layer, the method comprising:

inserting the needle into the patient to access the target tissue by puncturing with the needle an outer tissue structure overlaying the target tissue;

after the outer tissue structure is punctured, transmitting, to the target tissue, a first optical radiation using the optically-transmissive coating or the cladding layer;

receiving, from the target tissue, at a processor, a second optical radiation via the other of the optically-transmissive coating or the cladding layer based on the first optical radiation; and

determining, by the processor, based on the second optical radiation, data characterizing at least one of (i) at least one characteristic of the target tissue, (ii) at least one location of the target tissue, and (iii) a location of a tip of the needle with respect to the target tissue,

wherein the optically-transmissive coating is provided at least at a distal end of the needle.

2. The method of claim 1 , further comprising at least one of (i) administering a pharmacological agent to the at least one patient through the at least one lumen, (ii) exposing the pharmacological agent to the first optical radiation, and (iii) obtaining a biopsy sample from the at least one patient through the at least one lumen.

3. The method of claim 1 , further comprising, based on the data, ablating an area of the target tissue by applying a further optical radiation to the target tissue.

4. The method of claim 1 , further comprising determining a three-dimensional location of at least one portion of the insertion apparatus at or in a body based on the data.

5. The method of claim 1 , further comprising generating an image on a display of at least one portion of the insertion apparatus at or in a body in a three-dimensional space based on the data.

6. The method of claim 1 , wherein a second optically-transmissive coating circumferentially surrounds the optically-transmissive coating, the lumen and the cladding layer.

7. The method of claim 6 , wherein the optically-transmissive coating circumferentially comprises a plurality of outer core sections which are (a) provided on an outer surface of the cladding layer over and away from the lumen, and (b) optically separated from one another.

8. A method of determining information associated with at least one target tissue of a patient using a needle comprising at least one lumen extending along a length thereof, a cladding layer formed on an external surface of the needle and an optically-transmissive coating circumferentially surrounding an exterior of the cladding layer, the method comprising:

inserting the needle into the patient to access the target tissue by puncturing with the needle an outer tissue structure overlaying the target tissue;

after the outer tissue structure is punctured, transmitting, to the target tissue, a first optical radiation using the optically-transmissive coating or the cladding layer;

receiving, from the target tissue, at a processor, a second optical radiation via the other of the optically-transmissive coating or the cladding layer based on the first optical radiation; and

determining, by the processor, based on the second optical radiation, data characterizing at least one of (i) at least one characteristic of the target tissue, (ii) at least one location of the target tissue, and (iii) a location of a tip of the needle with respect to the target tissue,

wherein the optically-transmissive coating is provided at least at a distal end of the needle.

9. The method of claim 8 , further comprising providing the data to a user via at least one of an optical display, an auditory device and a haptic device communicatively coupled to the processor.

10. The method of claim 8 , further comprising providing an audible, tactile and/or visual alert to the needle based on the at least one characteristic of the target tissue.

11. The method of claim 8 , further comprising at least one of (i) administering a material and/or substance to the at least one patient through the at least one lumen, (ii) exposing the material and/or substance to the first optical radiation, and (iii) obtaining a biopsy sample from the at least one patient through the at least one lumen.

12. The method of claim 11 , wherein the at least one characteristic of the target tissue is indicative of cellulite in fat and the material and/or substance administered is an enzyme configured to break down fibrous cords in the fat.

13. The method of claim 12 , further comprising determining a three-dimensional location of at least one portion of the insertion apparatus within the fat before enzyme.

14. The method of claim 11 , wherein the at least one characteristic of the target tissue is indicative of an epidural fluid and the material and/or substance administered is a steroid.

15. The method of claim 11 , wherein the material and/or substance administered is a gel or cross-linkable monomer and the first optical radiation exposed to the gel or cross-linkable monomer is configured to polymerize the gel or cross-linkable monomer.

16. The method of claim 11 , wherein the material and/or substance administered is a photosensitizing agent.

17. The method of claim 11 , wherein the material and/or substance administered are stem cells or genetic materials.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 17, 2022
From: TING, JOE; TO, TANIA; ZUO, VINCENT; WRIGHT, JAMES; APOLLONIO, BEN; DRESSER, CHARLES HOLLAND
To: BLOSSOM INNOVATIONS
Reel/Frame 061812/0750 →
Continuity (5)
Division 16818640 · Mar 13, 2020
Provisional Application 62941202 · Nov 27, 2019
Provisional Application 62941213 · Nov 27, 2019
Provisional Application 62817914 · Mar 13, 2019
Related Publication 20230148867A1 · May 18, 2023
References Cited (183)
US 3313293A · Cheesbrough et al. · 1967 [cited by applicant]
US 3682162A · Colyer · 1972 [cited by applicant]
US 4312364A · Convert et al. · 1982 [cited by applicant]
US 4469109A · Mehl et al. · 1984 [cited by applicant]
US 4566183A · Bloom et al. · 1986 [cited by applicant]
US 5279306A · Mehl · 1994 [cited by applicant]
US 5294325A · Liu · 1994 [cited by applicant]
US 5341807A · Nardella · 1994 [cited by applicant]
US 5634924A · Turkel et al. · 1997 [cited by applicant]
US 5651783A · Reynard · 1997 [cited by examiner]
US 5658279A · Nardella et al. · 1997 [cited by applicant]
US 5904709A · Arndt et al. · 1999 [cited by applicant]
US 5947964A · Eggers et al. · 1999 [cited by applicant]
US 5997568A · Liu · 1999 [cited by applicant]
US 6117133A · Zappala · 2000 [cited by applicant]
US 6182666B1 · Dobak, III · 2001 [cited by applicant]
US 6230060B1 · Mawhinney · 2001 [cited by applicant]
US 6315777B1 · Comben · 2001 [cited by applicant]
US 6356783B1 · Hubbard, Jr. · 2002 [cited by applicant]
US 6371943B1 · Racz et al. · 2002 [cited by applicant]
US 6509521B1 · Geitz · 2003 [cited by applicant]
US 6673068B1 · Berube · 2004 [cited by applicant]
US 7160292B2 · Moorman et al. · 2007 [cited by applicant]
US 7488295B2 · Burbank et al. · 2009 [cited by applicant]
US 7862563B1 · Cosman · 2011 [cited by applicant]
US 8133033B2 · Abraham · 2012 [cited by applicant]
US 8396532B2 · Jenkins et al. · 2013 [cited by applicant]
US 8953911B1 · Xu · 2015 [cited by examiner]
US 10687730B2 · Kronström et al. · 2020 [cited by applicant]
US 10779804B2 · Kronstrom et al. · 2020 [cited by applicant]
US 11191446B2 · Ting et al. · 2021 [cited by applicant]
US 11432733B2 · Ting et al. · 2022 [cited by applicant]
US 20020042594A1 · Lum et al. · 2002 [cited by applicant]
US 20020072686A1 · Hoey et al. · 2002 [cited by applicant]
US 20020165448A1 · Ben-Haim · 2002 [cited by examiner]
US 20030078572A1 · Pearson et al. · 2003 [cited by applicant]
US 20030109871A1 · Johnson et al. · 2003 [cited by applicant]
US 20030187366A1 · Hashimshony · 2003 [cited by applicant]
US 20030195500A1 · Moorman et al. · 2003 [cited by applicant]
US 20040143218A1 · Das · 2004 [cited by applicant]
US 20050090820A1 · Cornelius et al. · 2005 [cited by applicant]
US 20050203505A1 · Megerman · 2005 [cited by applicant]
US 20050277829A1 · Tsonton · 2005 [cited by applicant]
US 20050279354A1 · Deutsch et al. · 2005 [cited by applicant]
US 20050288566A1 · Levendusky et al. · 2005 [cited by applicant]
US 20060190006A1 · Oka et al. · 2006 [cited by applicant]
US 20060285350A1 · Wang · 2006 [cited by applicant]
US 20070179491A1 · Kratoska et al. · 2007 [cited by applicant]
US 20070179508A1 · Arndt · 2007 [cited by applicant]
US 20070260156A1 · Hashimshony · 2007 [cited by applicant]
US 20080015570A1 · Ormsby et al. · 2008 [cited by applicant]
US 20080033424A1 · van der Weide et al. · 2008 [cited by applicant]
US 20090088711A1 · Shelley et al. · 2009 [cited by applicant]
US 20090112201A1 · Young · 2009 [cited by applicant]
US 20090171304A1 · Cao et al. · 2009 [cited by applicant]
US 20090295674A1 · Bonn · 2009 [cited by applicant]
US 20090306522A1 · Gono et al. · 2009 [cited by applicant]
US 20100004650A1 · Ormsby et al. · 2010 [cited by applicant]
US 20100204560A1 · Salahieh et al. · 2010 [cited by applicant]
US 20100268219A1 · Ormsby et al. · 2010 [cited by applicant]
US 20100286507A1 · Paassilta et al. · 2010 [cited by applicant]
US 20100298822A1 · Behnke · 2010 [cited by applicant]
US 20110077635A1 · Bonn · 2011 [cited by applicant]
US 20110098695A1 · Brannan · 2011 [cited by applicant]
US 20110212411A1 · Sinofsky · 2011 [cited by examiner]
US 20120310315A1 · Savage et al. · 2012 [cited by applicant]
US 20130116679A1 · Van Der Weide et al. · 2013 [cited by applicant]
US 20140088371A1 · Vayser · 2014 [cited by examiner]
US 20140133814A1 · Stevens et al. · 2014 [cited by applicant]
US 20140212083A1 · Pare · 2014 [cited by examiner]
US 20140228838A1 · Kirschenman · 2014 [cited by applicant]
US 20140303494A1 · Janicki et al. · 2014 [cited by applicant]
US 20140316254A1 · Eversull et al. · 2014 [cited by applicant]
US 20150119674A1 · Fischell et al. · 2015 [cited by applicant]
US 20150209105A1 · Margallo Balbas · 2015 [cited by examiner]
US 20150216442A1 · Lavy et al. · 2015 [cited by applicant]
US 20150272451A1 · Razavi et al. · 2015 [cited by applicant]
US 20150351670A1 · Vanslyke et al. · 2015 [cited by applicant]
US 20150374915A1 · Hyde et al. · 2015 [cited by applicant]
US 20160029920A1 · Kronström et al. · 2016 [cited by applicant]
US 20160066894A1 · Barton-Sweeney et al. · 2016 [cited by applicant]
US 20160081585A1 · Halter · 2016 [cited by applicant]
US 20160331290A1 · Oh et al. · 2016 [cited by applicant]
US 20170049378A1 · Schipper · 2017 [cited by applicant]
US 20170086801A1 · Furlong et al. · 2017 [cited by applicant]
US 20170143201A1 · Claude et al. · 2017 [cited by applicant]
US 20170172618A1 · Erkamp et al. · 2017 [cited by applicant]
US 20170254636A1 · Foster et al. · 2017 [cited by applicant]
US 20170311807A1 · Fu et al. · 2017 [cited by applicant]
US 20170354379A1 · Goyal et al. · 2017 [cited by applicant]
US 20180140278A1 · Bromberg et al. · 2018 [cited by applicant]
US 20180250217A1 · Davidson et al. · 2018 [cited by applicant]
US 20180296146A1 · Harttig · 2018 [cited by applicant]
US 20180296197A1 · Kronström et al. · 2018 [cited by applicant]
US 20180317896A1 · Kadamus et al. · 2018 [cited by applicant]
US 20180360342A1 · Fuimaono et al. · 2018 [cited by applicant]
US 20190029751A1 · Hancock et al. · 2019 [cited by applicant]
US 20190038348A1 · Koblish et al. · 2019 [cited by applicant]
US 20190125447A1 · Ben Oren · 2019 [cited by examiner]
US 20190200930A1 · Lowery · 2019 [cited by applicant]
US 20190328295A1 · Liu et al. · 2019 [cited by applicant]
US 20200037924A1 · Govari et al. · 2020 [cited by applicant]
US 20200289021A1 · Ting et al. · 2020 [cited by applicant]
US 20200367757A1 · Ting et al. · 2020 [cited by applicant]
US 20210085212A1 · Czaplewski-campbell et al. · 2021 [cited by applicant]
US 20210259573A1 · Ting et al. · 2021 [cited by applicant]
US 20210270705A1 · Van Der Zaag · 2021 [cited by examiner]
US 20220095925A1 · Ting et al. · 2022 [cited by applicant]
US 20220133152A1 · Ting et al. · 2022 [cited by applicant]
US 20240156352A1 · Ting et al. · 2024 [cited by applicant]
CN 101073497A · 2007 [cited by applicant]
CN 101917901A · 2010 [cited by applicant]
CN 204033333U · 2014 [cited by applicant]
CN 104739503A · 2015 [cited by applicant]
CN 103717249B · 2017 [cited by applicant]
CN 108601582A · 2018 [cited by applicant]
CN 108670174A · 2018 [cited by applicant]
CN 208447588U · 2019 [cited by applicant]
CN 106061420B · 2021 [cited by applicant]
DE 102017004548A1 · 2018 [cited by applicant]
JP 2011521672A · 2011 [cited by applicant]
JP 2015512711A · 2015 [cited by applicant]
JP 2016504090A · 2016 [cited by applicant]
WO 2014162242A1 · 2014 [cited by applicant]
WO 2015155671A1 · 2015 [cited by applicant]
WO WO2017058620A1 · 2017 [cited by examiner]
WO 2018015782A1 · 2018 [cited by applicant]
WO 2018175348 · 2018 [cited by applicant]
WO 2020186153A1 · 2020 [cited by applicant]
WO 2020186164A1 · 2020 [cited by applicant]
WO 2021054974A1 · 2021 [cited by applicant]
Restriction Requirement dated Sep. 16, 2022 for U.S. Appl. No. 16/818,640. [cited by applicant]
Advisory Action dated Oct. 18, 2022 for U.S. Appl. No. 17/438,816. [cited by applicant]
Final Office Action dated Jul. 15, 2022 for U.S. Appl. No. 17/438,816. [cited by applicant]
First Examination Report dated Aug. 9, 2022 for Australian Patent Application No. 2020391498. [cited by applicant]
Examiner's Report dated Jul. 13, 2022 for Canadian Patent Application No. 3163236. [cited by applicant]
Notice of Reasons for Rejection dated Dec. 6, 2022 for Japanese Patent Application No. 2022-531469. [cited by applicant]
European Search Report dated Dec. 9, 2022 for European Patent Application No. 20 892 204.7. [cited by applicant]
European Communication pursuant to Article 94(3) EPC dated Dec. 21, 2022 for European Patent Application No. 20 892 204.7. [cited by applicant]
Non Final Office Action dated Nov. 17, 2022 for U.S. Appl. No. 17/577,929. [cited by applicant]
Non Final Office Action dated Dec. 30, 2022 for U.S. Appl. No. 17/283,406. [cited by applicant]
Integral, www.dictionary.com/browse/integral, 7 pages, printed on Mar. 7, 2022 (Year: 2022). [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2020/022641 mailed on Jun. 15, 2020. [cited by applicant]
International Search Report and Written Opinion for International Patent Application No. PCT/US2020/022614 mailed on Jul. 1, 2020. [cited by applicant]
Advisory Action for U.S. Appl. No. 17/193,798 mailed on Mar. 4, 2022. [cited by applicant]
Non Final Office Action for U.S. Appl. No. 17/438,816 mailed on Feb. 18, 2022. [cited by applicant]
Notice of Allowance mailed on Apr. 8, 2022 for U.S. Appl. No. 16/801,060. [cited by applicant]
Burgher, Julie M et al., “Grove, Robert I, PhotoPoint photodynamic therapy with local drug delivery eliminates vessel wall cells in arteriovenous graft models,” Cardiovascular radiation medicine, ISSN: 1522-1865, vol. 3… [cited by applicant]
Abduljabbar, Mohammed H. et al., “Complications of hyaluronic acid fillers and their managements,” Journal of Dermatology & Dermatologic Surgery 20 (2016) 20, pp. 100-106. [cited by applicant]
Sepulveda, Abel et al., “Vascular Tumors,” Semin Plast Surg. May 2014; 28(2): 49-57. [cited by applicant]
Rocha, Rafael Dahmer et al., “Step-by-step of ultrasound-guided core-needle biopsy of the breast: review and technique,” Radiol Bras. Jul. 2013/Ago;46(4):234-241. [cited by applicant]
Schär, Dorothee et al., “Anti-infective therapy of peri-implantitis with adjunctive local drug delivery or photodynamic therapy: six-month outcomes of a prospective randomized clinical trial, Clinical Oral Implants Rese… [cited by applicant]
Selfridge, Alan et al., “Wideband Spherically Focused PVDF Acoustic Sources for Calibration of Ultrasound Hydrophone Probes,” IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control, vol. 47, No. 6, Nov.… [cited by applicant]
Yun, Joho et al., Micro electrical impedance spectroscopy on a needle for ex vivo discrimination between human normal and cancer renal tissues, Biomicrofluidics 10, 034109 (2016). [cited by applicant]
Ribatti, Domenico, et al., “Angiogenesis and Melanoma,” Cancers 2010, 2, 114-132. [cited by applicant]
Cano, Ivorra et al., Contributions to the measurement of electrical impedance for living tissue ischemia injury monitoring, Doctoral Thesis, Universitat Politècnica de Catalunya, 2005. [cited by applicant]
Joho Yun, Joho et al., “Fabrication of Fine Electrodes on the Tip of Hypodermic Needle Using Photoresist Spray Coating and Flexible Photomask for Biomedical,” Journal of Visualized Experiments, Nov. 2017 | 129 | e56622 … [cited by applicant]
Pelras, Théophile et al., “Transparent Low Molecular Weight Poly(Ethylene Glycol) Diacrylate-Based Hydrogels as Film Media for Photoswitchable Drugs,” Polymers 2017, vol. 9, p. 639 (2017). [cited by applicant]
Covidien, “Principles of Electrosurgery,” Boulder CO, pp. 1-28, 2008. [cited by applicant]
Liberman, Laura, “Percutaneous Imaging-Guided Core Breast Biopsy: State of the Art at the Millennium,” AJR:174, May 2000. [cited by applicant]
Canadian Examination Report dated Jul. 13, 2022 for Canadian Patent Application No. 3,163,236. [cited by applicant]
International Preliminary Report on Palatability for International Patent Application No. PCT/US2020/062415 mailed on Jun. 9, 2022. [cited by applicant]
Non Final Office Action mailed on Jun. 13, 2022 for U.S. Appl. No. 17/193,798. [cited by applicant]
Final Office Action mailed on Jul. 15, 2022 for U.S. Appl. No. 17/438,816. [cited by applicant]
Australian Examination Report No. 1 mailed on Aug. 9, 2022 for Australian Patent Application No. 2020391498. [cited by applicant]
Final Office Action mailed on May 18, 2023 for U.S. Appl. No. 17/577,929. [cited by applicant]
Notice Of Grounds for Rejections dated Dec. 22, 2022 for Korean Patent application No. 10-2022-7021725 (with English Translation). [cited by applicant]
Examiner's Report issued on Jan. 9, 2023 Canadian Application No. 3,163,236. [cited by applicant]
European Search Report dated Feb. 24, 2023 for European Patent Application No. 20770696. [cited by applicant]
Non Final Office Action mailed on Mar. 14, 2023 for corresponding U.S. Appl. No. 17/438,816. [cited by applicant]
European Search Report dated Feb. 24, 2023 for European Patent Application No. 20770696.1. [cited by applicant]
Communication Pursuant to Rules 70(2) and 70a(2) EPC dated Mar. 15, 2023 for European Patent Application No. 20770696.1. [cited by applicant]
Non Final Office Action dated Mar. 30, 2023 for U.S. Appl. No. 16/818,640. [cited by applicant]
Non Final Office Action dated Mar. 14, 2023 for U.S. Appl. No. 17/438,816. [cited by applicant]
Final Office Action dated May 18, 2023 for U.S. Appl. No. 17/577,929. [cited by applicant]
Final Office Action dated Jul. 14, 2023 for U.S. Appl. No. 17/438,816. [cited by applicant]
Office Action dated Jul. 14, 2023 for Taiwan Patent Application No. 109108435 w/English translation. [cited by applicant]
Office Action dated Jul. 19, 2023 for Taiwan Patent Application No. 109108451 w/English translation. [cited by applicant]
Bouma et al. (2017) “Intravascular optical coherence tomography [Invited]”, Biomedical Optics Express, 8(5):2660-2686. [cited by applicant]
Dukkipati et al. (Sep. 22, 2015) “Pulmonary Vein Isolation Using the Visually Guided Laser Balloon: A Prospective, Multicenter, and Randomized Comparison to Standard Radiofrequency Ablation”, Journal of the American Col… [cited by applicant]
Goldman et al. (May 2015) “Phase 2a, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study of Repeat Doses of Collagenase Clostridium Histolyticum for the Treatment of Edematous Fibrosclerotic Panniculopathy (… [cited by applicant]
Utzinger et al. (Jan. 2003) “Fiber Optic Probes for Biomedical Optical Spectroscopy”, Journal of Biomedical Optics, 8(1):121-147. [cited by applicant]
Wheeler et al. (1992) “Statistical Tolerance Intervals (1992). Understanding Statistical Process Control. Quality Digest”, [From the Internet] https:itwww.qualitydigest.com/inside/statistics-column/stattistical-toleranc… [cited by applicant]